Moving young people with sickle cell disease from paediatric to adult services

Jo Howard1, Tanya Woodhead, Luhanga Musumadi

  • 1Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London.

Insights

This review examines the transition of care for pediatric patients with sickle cell disease (SCD) to adult services. It highlights strategies implemented by a major UK center to manage this critical phase for inherited blood disorder patients.

Area of Science:

  • Hematology
  • Pediatrics
  • Internal Medicine

Background:

  • Sickle cell disease (SCD) is the most common inherited blood disorder in the UK.
  • Transitioning care from pediatric to adult services presents unique challenges for SCD patients.
  • Effective management of this transition is crucial for long-term patient outcomes.

Purpose of the Study:

  • To review existing data on the transition process for pediatric SCD patients to adult care.
  • To outline the specific approaches adopted by a large UK sickle cell center to facilitate this transition.
  • To identify best practices for improving care coordination during this critical phase.

Main Methods:

  • Literature review of data concerning SCD care transition.
  • Analysis of service delivery models in a major UK sickle cell center.
  • Qualitative and quantitative assessment of transition protocols.

Main Results:

  • Identified key challenges in the pediatric to adult care transition for SCD patients.
  • Described a comprehensive transition program implemented at a UK center.
  • Highlighted the importance of multidisciplinary team involvement and patient-centered planning.

Conclusions:

  • A structured transition program is essential for optimizing care for young adults with SCD.
  • Successful transition requires collaboration between pediatric and adult healthcare providers.
  • Continued research and service development are needed to address the evolving needs of SCD patients.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...